Investigating Meningococcal Vaccines in Adults - An Exploratory, Open-label, Immunogenicity Study of a Licensed Meningococcal Capsular Group B Vaccine (4CMenB, Bexsero) in Adults

Trial Profile

Investigating Meningococcal Vaccines in Adults - An Exploratory, Open-label, Immunogenicity Study of a Licensed Meningococcal Capsular Group B Vaccine (4CMenB, Bexsero) in Adults

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 01 Apr 2017

At a glance

  • Drugs Meningococcal vaccine group B (Primary)
  • Indications Meningococcal group B infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 28 Mar 2017 Planned End Date changed from 1 Dec 2016 to 1 Apr 2017.
    • 13 Oct 2016 Planned End Date changed from 1 Aug 2016 to 1 Dec 2016.
    • 13 Oct 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Dec 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top